In one paragraphArticle in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
8 authors.
Silvânia Mól PelinsariDepartment of General Biology, Federal University of Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0009-0005-4051-1600 Patricia da Silva MattosinhosDepartment of General Biology, Federal University of Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0002-8482-2305 Manoela Maciel Dos Santos DiasDepartment of Animal Biology, Federal University of Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0001-6791-0680 Rosinéa Aparecida de PaulaDepartment of Animal Biology, Federal University of Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0002-4256-7473 Romulo Dias NovaesDepartment of Structural Biology, Biomedical Science Institute, Federal University of Alfenas, Alfenas 37130-000, MG, Brazil.ORCID 0000-0002-3186-5328 Emerson Ferreira VilelaMinas Gerais Agricultural Research Agency (EPAMIG Sul), Experimental Field of São Sebastião do Paraíso, São Sebastião do Paraíso 37959-899, MG, Brazil.ORCID 0009-0002-0671-2087 Giuseppe ValacchiDepartment of Animal Science, Plants for Human Health Institute, North Carolina State University, Kannapolis, NC 28081, USA.ORCID 0000-0002-8792-0947 Reggiani Vilela GonçalvesDepartment of General Biology, Federal University of Viçosa, Viçosa 36570-900, MG, Brazil.ORCID 0000-0002-5831-3590 Funding
Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88882.461705/2019-01Coordenação de Aperfeicoamento de Pessoal de Nível Superior 88887.714456/2022-00Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-03519-22Fundação de Amparo à Pesquisa do Estado de Minas Gerais APQ-04164-22National Council for Scientific and Technological Development 310413/2023-0
6 · The paper itselfAbstract
(1) Background: This study evaluated the potential of a synthetic peptide (SGHPGAMGPVGPR), identified in the bullfrog (
Indexed as
Anti-Inflammatory AgentsInflammationOxidative StressPeptidesSkinAnimalsAntioxidantsCell SurvivalCyclooxygenase 2MacrophagesMiceMolecular Docking SimulationNitric OxideRAW 264.7 CellsSuperoxide DismutaseTumor Necrosis Factor-alphaAnti-Inflammatory AgentsAntioxidantsCyclooxygenase 2Nitric OxidePeptidesSuperoxide DismutaseTumor Necrosis Factor-alphabullfrogcytokinesinflammatory responsepeptidesskin diseases
Identifiers
PMID40430395
PMCPMC12114019
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390